ロード中...
Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial
PURPOSE: A phase II, open-label, dose-finding, randomized study was performed to evaluate the recommended dose of pegfilgrastim in Japanese breast cancer patients. METHODS: Patients received 1.8, 3.6, or 6.0 mg of pegfilgrastim once per chemotherapy cycle for up to 6 cycles. Patients received doceta...
保存先:
| 出版年: | Support Care Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4552775/ https://ncbi.nlm.nih.gov/pubmed/25733000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-015-2654-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|